XC
AAPG

XY Capital’s Ascentage Pharma AAPG Stock Holding History

XY Capital’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$311K Sell
13,014
-614
-5% -$15.1K 0.31% 39
2025
Q4 		$358K Sell
13,628
-4,492
-25% -$147K 0.23% 94
2025
Q3 		$707K Buy
18,120
+12,530
+224% +$507K 0.37% 68
2025
Q2 		$220K Sell
5,590
-17,915
-76% -$472K 0.15% 37
2025
Q1 		$516K Buy
+23,505
New +$446K 0.15% 117

Other funds holding AAPG

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

XY Capital's AAPG Position: Q1 2026 in Review

XY Capital reduced its Ascentage Pharma (AAPG) stake by 4.5% in Q1 2026, selling an estimated $15.1K and leaving 13,014 shares worth $311K. The position accounts for 0.31% of the portfolio, ranked #39.

XY Capital first reported a position in AAPG in Q1 2025 and has held it in 5 quarters since. The position peaked at $707K in Q3 2025. 7 funds tracked by Wall St. Rank hold AAPG as of Q1 2026.

  • XY Capital held 13,014 shares of Ascentage Pharma worth $311K as of Q1 2026.
  • XY Capital sold 614 Ascentage Pharma shares in Q1 2026, an estimated $15.1K.
  • Ascentage Pharma made up 0.31% of XY Capital's portfolio in Q1 2026, its #39 holding.
  • XY Capital first reported a position in Ascentage Pharma in Q1 2025 and has held it in 5 quarters since.
  • XY Capital's Ascentage Pharma position peaked at $707K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Ascentage Pharma as of Q1 2026.

Based on XY Capital's 13F filing for Q1 2026, filed 12 May 2026.